Mercury Laboratories Ltd reports an 88.08% year-on-year increase in standalone net profit to ₹39.19 crore for the quarter ended 30 June 2026 (Q1 FY27), compared with ₹20.84 crore in the same quarter of the previous fiscal year. The company’s revenue from operations rises to ₹1,596.32 crore from ₹1,044.24 crore, while total income increases to ₹1,601.54 crore from ₹1,070.09 crore. Total expenses for the quarter are ₹1,562.35 crore versus ₹1,040.64 crore a year earlier. Earnings per share improve to ₹2.48 from ₹1.30. The company’s board meeting on 25 July 2026 approves unaudited standalone results, which are subject to a limited review by statutory auditors indicating no material misstatement.

In a separate filing, Prudent Corporate Advisory Services Ltd reports a consolidated net profit after tax of ₹74.76 crore for Q1 FY27, up from ₹20.84 crore referenced for the year-ago period in its release. Consolidated revenue from operations increases to ₹347.63 crore from ₹293.76 crore, and total consolidated income rises to ₹368.46 crore from ₹304.03 crore. Consolidated expenses increase to ₹268.23 crore from ₹234.44 crore, with profit before tax rising to ₹100.23 crore from ₹69.59 crore. Basic and diluted EPS stand at ₹18.05. The board approves unaudited standalone and consolidated results on 25 July 2026, with the meeting held between 12:30 PM and 01:50 PM.